Business
The Ginzton Technology Center acts
as Varian Medical Systems' research
and development facility for breakthrough
technologies and operates a
brachytherapy business for the delivery
of internal radiation to treat cancer.
In addition to brachytherapy, current
efforts are focused on emerging
biotechnologies that shrink tumors
by triggering therapeutic gene activity
with radiation beams. This business
also conducts externally funded
contract research related to medical
technology, which leads to long-term
partnerships and new business opportunities.
Products & Services
VariSource™ high-dose-rate BrachyTherapy ª delivery systems
VariSeed™ BrachyTherapy treatment planning software for seed placement
|
|
1999 Highlights
The Ginzton Technology Center enhanced
the VariSource product line with the development
of two new models, including a
transportable unit, for high-dose-rate
brachytherapy. The center established a
new VariSeed treatment planning product
for permanent seed implants in low-dose-rate
brachytherapy through the acquisition
of the Therapy Planning Systems Division
of Multimedia Medical Systems, Inc. The
center also secured contracts to investigate
digital imaging technologies for medical
applications, such as targeting prostate
tumors.
Outlook
Demand for minimally invasive procedures is expected to lead to sales growth of products for high- and low-dose-rate brachytherapy, particularly in international markets. The new VariSeed software tool for low-dose-rate prostate cancer brachytherapy planning will serve as a new revenue source for this business.
Facilities
Charlottesville, Virginia
Crawley, England
Mountain View, California (headquarters)
|
